An overview of progress in human metapneumovirus (hMPV) research: Structure, function, and therapeutic opportunities

Le résumé fourni par la source

• Human metapneumovirus (hMPV) is a respiratory virus that causes severe infections in infants, children, and the elderly. • We examine the virus’s structure and replication and highlight prophylaxis and treatment for hMPV infections. • hMPV entry/fusion/release inhibitors, hMPV RNA polymerase inhibitors, and host kinase inhibitors of hMPV were highlighted. The human metapneumovirus (hMPV), a member of the Pneumoviridae family, is a significant respiratory pathogen that causes severe infections in infants, children, the elderly, adults with chronic illnesses, and individuals with immunocompromised conditions. Globally, hMPV is recognized as the second leading cause of bronchiolitis and pneumonia among children under five. The absence of targeted antiviral treatments or vaccines for hMPV significantly strains the global health-care system. This review summarizes recent advances and scientific findings on hMPV by reviewing the current literature on its life cycle, structure, function, prevention, and treatment options.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.